Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed)

The National Cancer Institute (NCI) is soliciting applications for the Carcinogen Hazard Assessment Monographs Program (CHAMP) under an R01 mechanism. Applicants will develop systematic, evidence‑based monographs that evaluate the carcinogenic hazard of chemicals, agents, or exposures to humans. The goal is to identify cancer risks, inform prevention strategies, and shape health policy. Funding is limited to one award with an estimated total of $800,000 (award ceiling $700,000). Eligible entities include a wide range of public, private, nonprofit, tribal, and foreign organizations (excluding foreign components of U.S. entities). The application window opens January 9 2027 and closes February 9 2027; the award is anticipated by October 1 2026. Successful applicants must submit a data‑management and sharing plan and comply with NIH’s reporting requirements. • R01 research‑project grant (up to $700‑$800 K) • Focus on systematic review and monograph creation for carcinogen hazard assessment • Open to universities, research institutes, NGOs, tribal entities, and foreign organizations • Requires adherence to NIH application guidelines and data‑sharing policies • Award expected to start Oct 2026, with review in July–August 2027.